ValiRx plc (LON:VAL – Get Free Report) shares passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 0.27 and traded as low as GBX 0.15. ValiRx shares last traded at GBX 0.15, with a volume of 455,555 shares trading hands.
ValiRx Trading Up 1.9%
The company has a market cap of £2.15 million, a price-to-earnings ratio of -0.30 and a beta of 0.59. The company has a current ratio of 4.62, a quick ratio of 1.27 and a debt-to-equity ratio of 0.05. The business’s 50 day moving average price is GBX 0.18 and its 200-day moving average price is GBX 0.27.
ValiRx (LON:VAL – Get Free Report) last announced its quarterly earnings results on Monday, June 22nd. The company reported GBX (0.54) EPS for the quarter. The company had revenue of GBX 3 million during the quarter. ValiRx had a negative net margin of 7,115.36% and a negative return on equity of 70.79%. On average, equities analysts anticipate that ValiRx plc will post -1.74 EPS for the current fiscal year.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Further Reading
- Five stocks we like better than ValiRx
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
